{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:29:16Z","timestamp":1787696956588,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1124\/jpet.111.189100","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T06:16:36Z","timestamp":1323152196000},"page":"612-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats"],"prefix":"10.1016","volume":"340","author":[{"given":"Tanuja","family":"Bordia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryka","family":"Quik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.189100_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11940-011-0117-x","article-title":"Tardive dyskinesia","volume":"13","author":"Aia","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1124\/jpet.111.189100_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.111.189100_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2003.08.058","article-title":"Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats","volume":"122","author":"Andreassen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.189100_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-0270(90)90139-7","article-title":"The use of 3H standards in 125I autoradiography","volume":"32","author":"Artymyshyn","year":"1990","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.111.189100_bib5","first-page":"131","article-title":"Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia","volume":"14","author":"Barroso-Chinea","year":"2010","journal-title":"Front Neuroanat"},{"key":"10.1124\/jpet.111.189100_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson\u2019s disease","volume":"327","author":"Bordia","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.189100_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization","volume":"333","author":"Bordia","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.189100_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in l-DOPA-induced dyskinesia","volume":"183","author":"Cenci","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.111.189100_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn2849","article-title":"Nicotine addiction and nicotinic receptors: lessons from genetically modified mice","volume":"11","author":"Changeux","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.111.189100_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eurpsy.2008.07.007","article-title":"Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial","volume":"24","author":"Diehl","year":"2009","journal-title":"Eur Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/B978-0-444-52014-2.00042-2","article-title":"Typical and atypical neuroleptics","volume":"100","author":"Gershanik","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/jpet.111.189100_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.189100_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.111.182949","article-title":"Nicotine reduces l-DOPA-induced dyskinesias by acting at \u03b22* nicotinic receptors","volume":"338","author":"Huang","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.189100_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","article-title":"Nicotinic receptor agonists decrease l-DOPA-induced dyskinesias most effectively in moderately lesioned parkinsonian rats","volume":"60","author":"Huang","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.189100_bib16","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.111.189100_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(72)90086-6","article-title":"Morphine catalepsy in the rat: relation to striatal dopamine metabolism","volume":"19","author":"Kuschinsky","year":"1972","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.189100_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4522(97)00447-8","article-title":"Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat","volume":"84","author":"Levinson","year":"1998","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.189100_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","article-title":"The dopamine transporter and attention-deficit\/hyperactivity disorder","volume":"57","author":"Madras","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1460-9568.2002.01944.x","article-title":"Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to \u201cearly onset\u201d vacuous chewing","volume":"15","author":"Marchese","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.111.189100_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","article-title":"Guidelines on nicotine dose selection for in vivo research","volume":"190","author":"Matta","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.189100_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp.64.6.799","article-title":"Persistent loss of tyrosine hydroxylase immunoreactivity in the substantia nigra after neuroleptic withdrawal","volume":"64","author":"Mazurek","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0006-3223(91)90163-G","article-title":"Smoking and movement disorders in psychiatric patients","volume":"30","author":"Menza","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.189100_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0006-3223(96)00289-2","article-title":"Cigarette smoking is associated with abnormal involuntary movements in the general male population\u2013a study of men born in 1933","volume":"41","author":"Nilsson","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2741\/2695","article-title":"Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer\u2019s and Parkinson\u2019s disease","volume":"13","author":"Picciotto","year":"2008","journal-title":"Front Biosci"},{"key":"10.1124\/jpet.111.189100_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.21203","article-title":"Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys","volume":"62","author":"Quik","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.111.189100_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2007.03.001","article-title":"Nicotine neuroprotection against nigrostriatal damage: importance of the animal model","volume":"28","author":"Quik","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.111.189100_bib29","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates","volume":"98","author":"Quik","year":"2006","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.189100_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2011.06.001","article-title":"Role of \u03b16 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders","volume":"82","author":"Quik","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.189100_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.189100_bib32","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/pr.110.003269","article-title":"\u03b16\u03b22* and \u03b14\u03b22* Nicotinic acetylcholine receptors as drug targets for Parkinson\u2019s disease","volume":"63","author":"Quik","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.111.189100_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2011.03.003","article-title":"Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons","volume":"1394","author":"Reynolds","year":"2011","journal-title":"Brain Res"},{"key":"10.1124\/jpet.111.189100_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/syn.20078","article-title":"Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia","volume":"54","author":"Rogoza","year":"2004","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.189100_bib35","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med"},{"key":"10.1124\/jpet.111.189100_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2008.01.010","article-title":"Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery","volume":"64","author":"Samaha","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneumeth.2005.02.004","article-title":"Novel oral drug administration in an animal model of neuroleptic therapy","volume":"146","author":"Schleimer","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.111.189100_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1124\/jpet.111.189100_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.111.189100_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/B978-0-444-52014-2.00043-4","article-title":"Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs","volume":"100","author":"Tarsy","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1124\/jpet.111.189100_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front Syst Neurosci"},{"key":"10.1124\/jpet.111.189100_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00213-002-1259-z","article-title":"The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats","volume":"165","author":"Turrone","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.189100_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.111.189100_bib44","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1517\/14656560903061309","article-title":"Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making","volume":"10","author":"Volavka","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/jpet.111.189100_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.111.189100_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-3223(87)90131-4","article-title":"Nicotine exposure and tardive dyskinesia","volume":"22","author":"Yassa","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib47","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.pnpbp.2011.06.006","article-title":"Smoking and tardive dyskinesia in male patients with chronic schizophrenia","volume":"35","author":"Zhang","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.111.189100_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2007.04.007","article-title":"Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment","volume":"420","author":"Zhang","year":"2007","journal-title":"Neurosci Lett"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524467608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.189100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:57:25Z","timestamp":1743202645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524467608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022356524467608"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.189100","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.189100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}